Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Inhibition of hepatitis C virus production by aptamers against the core protein.

Shi S, Yu X, Gao Y, Xue B, Wu X, Wang X, Yang D, Zhu H.

J Virol. 2014 Feb;88(4):1990-9. doi: 10.1128/JVI.03312-13. Epub 2013 Dec 4.

2.

Inhibition of hepatitis C virus infection by NS5A-specific aptamer.

Yu X, Gao Y, Xue B, Wang X, Yang D, Qin Y, Yu R, Liu N, Xu L, Fang X, Zhu H.

Antiviral Res. 2014 Jun;106:116-24. doi: 10.1016/j.antiviral.2014.03.020. Epub 2014 Apr 5.

PMID:
24713119
3.

Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein.

Yang D, Meng X, Yu Q, Xu L, Long Y, Liu B, Fang X, Zhu H.

Antimicrob Agents Chemother. 2013 Oct;57(10):4937-44. doi: 10.1128/AAC.00897-13. Epub 2013 Jul 22.

4.

Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.

Gao Y, Yu X, Xue B, Zhou F, Wang X, Yang D, Liu N, Xu L, Fang X, Zhu H.

PLoS One. 2014 Feb 28;9(2):e90333. doi: 10.1371/journal.pone.0090333. eCollection 2014.

5.

CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.

Chen F, Hu Y, Li D, Chen H, Zhang XL.

PLoS One. 2009 Dec 3;4(12):e8142. doi: 10.1371/journal.pone.0008142.

6.

Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.

Bellecave P, Cazenave C, Rumi J, Staedel C, Cosnefroy O, Andreola ML, Ventura M, Tarrago-Litvak L, Astier-Gin T.

Antimicrob Agents Chemother. 2008 Jun;52(6):2097-110. doi: 10.1128/AAC.01227-07. Epub 2008 Mar 17.

7.

Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication.

Shanmugam S, Saravanabalaji D, Yi M.

J Virol. 2015 Apr;89(8):4562-74. doi: 10.1128/JVI.00123-15. Epub 2015 Feb 11.

PMID:
25673706
8.

Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.

Tellinghuisen TL, Foss KL, Treadaway J.

PLoS Pathog. 2008 Mar 21;4(3):e1000032. doi: 10.1371/journal.ppat.1000032.

9.

Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly.

Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R.

PLoS Pathog. 2008 Mar 28;4(3):e1000035. doi: 10.1371/journal.ppat.1000035.

10.

Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.

Lee CH, Lee YJ, Kim JH, Lim JH, Kim JH, Han W, Lee SH, Noh GJ, Lee SW.

J Virol. 2013 Jun;87(12):7064-74. doi: 10.1128/JVI.00405-13. Epub 2013 Apr 17.

11.

Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.

Galli A, Scheel TK, Prentoe JC, Mikkelsen LS, Gottwein JM, Bukh J.

J Gen Virol. 2013 Oct;94(Pt 10):2221-35. doi: 10.1099/vir.0.053868-0. Epub 2013 Aug 1.

PMID:
23907394
12.

Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen.

Lee S, Kim YS, Jo M, Jin M, Lee DK, Kim S.

Biochem Biophys Res Commun. 2007 Jun 22;358(1):47-52. Epub 2007 Apr 19.

PMID:
17475212
13.

Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.

Neveu G, Barouch-Bentov R, Ziv-Av A, Gerber D, Jacob Y, Einav S.

PLoS Pathog. 2012;8(8):e1002845. doi: 10.1371/journal.ppat.1002845. Epub 2012 Aug 16.

14.

A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus.

Jones DM, Atoom AM, Zhang X, Kottilil S, Russell RS.

J Virol. 2011 Dec;85(23):12351-61. doi: 10.1128/JVI.05313-11. Epub 2011 Sep 28.

15.

Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.

Hiasa Y, Kuzuhara H, Tokumoto Y, Konishi I, Yamashita N, Matsuura B, Michitaka K, Chung RT, Onji M.

Hepatology. 2008 Jul;48(1):59-69. doi: 10.1002/hep.22289.

PMID:
18459156
16.

Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.

Nag A, Robotham JM, Tang H.

J Virol. 2012 Dec;86(23):12616-24. doi: 10.1128/JVI.01351-12. Epub 2012 Sep 12.

17.

High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.

Jones LA, Clancy LE, Rawlinson WD, White PA.

Antimicrob Agents Chemother. 2006 Sep;50(9):3019-27.

18.

Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.

Das S, Shetty RK, Kumar A, Shridharan RN, Tatineni R, Chi G, Mukherjee A, Das S, Subbarao SM, Karande AA.

PLoS One. 2013;8(1):e53619. doi: 10.1371/journal.pone.0053619. Epub 2013 Jan 15.

19.

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production.

Lin CC, Tsai P, Sun HY, Hsu MC, Lee JC, Wu IC, Tsao CW, Chang TT, Young KC.

J Hepatol. 2014 Nov;61(5):984-93. doi: 10.1016/j.jhep.2014.06.026. Epub 2014 Jul 1.

PMID:
24996046
20.

Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A.

J Virol. 2001 Sep;75(17):8240-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk